Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Cancer funding boost and development of Australian Cancer Plan
The Australian Government is investing an additional $6.7 million to support and improve outcomes for…
The cancer workforce
The key to unlocking the promise of Europe’s beating cancer plan Ahead of a meeting…
Researchers explain the toxicity of USP7 inhibitors, under development for cancer treatment
Understanding the components that control cell division is fundamental to understanding how life works and…
Silica dust – the cancer risk tradies cannot see
Cancer Council Australia raises awareness of silica dust risk during Safe Work Month (October) With new estimates showing that over…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.